# RAAS Inhibitor Drugs in Dialysis Patients

> **NCT01635387** · PHASE4 · UNKNOWN · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 350 (estimated)

## Conditions studied

- Hypertension
- End Stage Renal Disease

## Interventions

- **DRUG:** aliskiren

## Key facts

- **NCT ID:** NCT01635387
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2012-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635387, "RAAS Inhibitor Drugs in Dialysis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01635387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*